000 01690 a2200433 4500
005 20250515072824.0
264 0 _c20090122
008 200901s 0 0 eng d
022 _a0753-3322
024 7 _a10.1016/j.biopha.2007.05.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrassi, Fernanda
245 0 0 _aQuinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cSep 2008
300 _a430-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHTLV-I Infections
_xpathology
650 0 4 _aHumans
650 0 4 _aIndicators and Reagents
650 0 4 _aMonocytes
_xdrug effects
650 0 4 _aQuinolines
_xpharmacology
650 0 4 _aTetrazolium Salts
650 0 4 _aTrypan Blue
700 1 _aGuimarães Corrêa, Ana Beatriz
700 1 _aMascarenhas, Rita Elizabeth
700 1 _aGalvão, Bernardo
700 1 _aSéon-Méniel, Blandine
700 1 _aSchmidt, Fanny
700 1 _aFranck, Xavier
700 1 _aHocquemiller, Reynald
700 1 _aFigadère, Bruno
700 1 _aFournet, Alain
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 62
_gno. 7
_gp. 430-5
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2007.05.003
_zAvailable from publisher's website
999 _c17124693
_d17124693